Medical biotechnology industry

FILE - This Aug. 23, 2019, file photo shows the New York Stock Exchange in New York. The U.S. stock market opens at 9:30 a.m. EDT on Tuesday, Oct. 22. (AP Photo/Frank Franklin II, File)
October 22, 2019 - 2:42 pm
The major U.S. stock indexes wavered between small gains and losses in late-afternoon trading Tuesday as investors weighed a mixed batch of earnings reports from McDonald's, Procter & Gamble and other big companies. Trading was choppy for much of the day, though outside of the Nasdaq, the moves...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 7:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 2:29 am
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology involving...
Read More
February 25, 2019 - 7:29 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. Danaher said after tax benefits,...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 08, 2018 - 11:24 pm
NEW YORK (AP) — Republican U.S. Rep. Christopher Collins of New York was arrested Wednesday on charges he fed inside information he gleaned from sitting on the board of a biotechnology corporation to his son, helping family and friends dodge hundreds of thousands of dollars in losses when one of...
Read More